Pall to Open Latest Life Sciences Centre of Excellence in Portsmouth (UK)
April 4, 2013
PORT WASHINGTON, N.Y., - Pall Corporation (NYSE:PLL), a global leader in filtration, separation and purification, today confirmed plans for a state-of–the-art Life Sciences Centre of Excellence at its new Harbourgate site in Portsmouth in the United Kingdom (UK). The Centre of Excellence (COE), which will open in mid 2013, will offer a full suite of [...]
Asuragen launches SuraSeq™ Next Generation Sequencing Services
April 4, 2013
Austin, Texas – Asuragen Inc., a leading molecular diagnostic company, announced today the launch of its SuraSeq™ Next Generation Sequencing (NGS) Service in its GLP compliant Genomics Services Laboratory. Asuragen’s SuraSeq™ NGS Service was developed specifically for targeted DNA mutation analysis from FFPE and FNA tumor samples to identify both known and de novo mutations. [...]
Life Technologies Launches Oncomine® Bioinformatics Solutions for Cancer Researchers
April 4, 2013
CARLSBAD, Calif., -- Life Technologies Corporation (NASDAQ: LIFE) announced today the introduction of two bioinformatics offerings - Oncomine(R) Gene Browser and Ion Reporter(TM) Oncomine(R) Workflow - that will allow cancer researchers new avenues of access to one of the largest genomics databases available, compiled by the former Compendia Bioscience. Both products will be featured in [...]
Dotmatics to Highlight Collaborative Mobile Data Sharing Platform at BioIT World
April 4, 2013
Bishops Stortford, -- Dotmatics announced today that the company will be showcasing its wide array of industry leading mobile and cloud based informatics solutions at BioIT World, to be held on April 9-12thin Boston, MA. Dotmatics Informatics platform enables data-driven organizations to collaborate and access information, simply and securely, increasing productivity and reducing time to [...]
April 4, 2013
Aliso Viejo, CA –– Ambry Genetics announced today that they have launched a somatic variant detection service, developed in collaboration with Illumina. This service complements Ambry’s extensive menu of next-generation sequencing services and portfolio of diagnostic genetic testing panels for hereditary cancers. Ambry Genetics has offered next-generation sequencing services since 2007 and has been at [...]
Spectro Inc. Wins U.S. Patent on Flip-Top Sample Head For Spectroscopic Analyzers
April 4, 2013
CHELMSFORD, MA – Spectro Inc., a global supplier of oil and fuel analysis instruments to industry and the military, has been awarded a U.S. patent for an innovative flip- top sample head for infrared spectrometers used in fluids analysis. Compared to conventional flow-through cells, the patented head’s flip-top cell improves convenience and efficiency while enabling [...]
VWR International, LLC Acquires Basan UK Limited
April 4, 2013
RADNOR, PA, - VWR International, LLC, a global provider of laboratory supplies, equipment and services announced today the acquisition of Basan UK Limited, a leading distributor of cleanroom products and services. VWR enables science globally by providing product and service solutions to laboratories and production facilities to drive advancements in healthcare, technology, science education and [...]
April 4, 2013
MENLO PARK, CA — LamdaGen Corporation, a nano-technology platform company that provides plasmonic sensors and systems for diagnostics and life sciences, announced the Japanese Patent Office issuance of patent number 5203390, “Enzymatic Assays for LSPR”, which enables highly sensitive and quantitative diagnostics. “The issuance of this patent underscores LamdaGen’s unique ability to harness the significant [...]
Illumina Launches TruSight™ Tumor Content Set
April 4, 2013
SAN DIEGO -- Illumina, Inc. (NASDAQ:ILMN) today announced the next product in its TruSight line of content sets, TruSight Tumor, for NGS-based somatic variant detection in solid tumors. TruSight Tumor provides optimized amplicon-based library preparation of 26 oncogenes and tumor suppressor genes selected for their involvement in common solid tumors, including lung, colon, melanoma, gastric, [...]
April 4, 2013
Cellectricon today announced the launch of its Discovery Services division. The new services offer pharma/biotech companies and CROs cutting-edge phenotypic screening support, accelerating drug discovery and cell-based assay research into cytoskeletal disturbances – especially for chronic pain. Cellectricon’s Discovery Services aim to help drug discovery teams shorten lead development times and reduce costs. With leading [...]

